Company: AMTX
Filing Date: 2025-02-12
Form Type: 424B5
Source: 0001437749-25-003485
Chunk: 16

Company: AEMETIS, INC
Filing Date: 2025-02-12
Form: 424B5
Chunk 16
---
 share, being the last reported sale price of our common stock on the Nasdaq Global Market on February 5, 2025, and after deducting commissions and estimated offering expenses payable by us, our as adjusted net tangible book deficit as of September 30, 2024, would have been approximately $213.0 million, or $3.00 per share of common stock. This represents an increase in net tangible book value compared to the net tangible book deficit as of September 30, 2024, of $2.46 per share to our existing stockholders and an immediate dilution of $5.11 per share to new investors in this offering.

The following table illustrates this calculation on a per share basis. The as adjusted information is illustrative only and will adjust based on the actual price to the public, the actual number of shares sold, and other terms of the offering determined at the time shares of our common stock are sold pursuant to this prospectus supplement. The as adjusted information assumes that all of our available shares authorized by our certificate of incorporation are sold at the assumed offering price of $2.11 per share. The shares sold in this offering, if any, will be sold from time to time at various prices.

| Assumed public offering price per share                                                                
 Historical net tangible book value (deficit) per share as of September 30, 2024                        |     |     | (5.46) |     |  2.11 |
|:-------------------------------------------------------------------------------------------------------|:----|:----|-------:|:----|------:|
| Increase in net tangible book value (deficit) per share attributable to new investors in this offering |     |     |   2.46 |     |       |
| As adjusted net tangible book value (deficit) per share immediately after this offering                |     |     |        |     | -3.00 |
| Dilution per share to new investors in this offering                                                   |     |     |      $ |     |  5.11 |

The foregoing table is based on 47,817,000 shares outstanding and does not give effect to the exercise of any outstanding options or warrants. To the extent options and warrants are exercised, there may be further dilution to new investors.

The shares subject to the sales agreement with the distribution agent are being sold from time to time at various prices. An increase of $1.00 per share in the price at which the shares are sold from the assumed offering price of $2